Skip to search formSkip to main contentSkip to account menu

TAK 603

Known as: TAK-603 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

QuinolinesTriazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
administration of T helper 1 inhibitor, TAK-603 Prevention of lethal acute graft-versus-host disease in mice by oral
2007
2007
Differential Requirement for a Cellular Type-1 Immune Response in Tumor-Associated Versus Alloantigen-Targeted GvT Effects
Background. The major obstacles that impair successful outcome after allogeneic hematopoietic stem cell transplantation (HSCT… 
2007
2007
Biol. Pharm. Bull. 30(8) 1438—1444 (2007)
dimethoxy-17-methylmorphinan-6-one, SIN) is a bioactive alkaloid derived from the Chinese medicinal plant, Sinomenium acutum… 
2004
2004
T helper 1 inhibitor TAK-603 inhibits IFN-gamma and IL-12 production with no effect on IL-18: an observation in sarcoidosis patients.
BACKGROUND AND AIM Sarcoidosis is immunologically characterized by highly enhanced Th1 responses in active stage. TAK-603 is a… 
2004
2004
T helper 1 inhibitor TAK-603 inhibits IFN-γ and IL-12 production with no effect on IL-18 : an observation in sarcoidosis patients
2002
2002
TAK-603, new rheumatic drug, inhibits rat mixed lymphocyte reactions and prolonges rat skin allograft survival.
2001
2001
The T helper (Th) 1 inhibitor TAK-603 seems to attenuate acute graft-versus-host disease
  • 2001
  • Corpus ID: 195159080
1999
1999
Studies on disease-modifying antirheumatic drugs. IV. Synthesis of novel thieno[2,3-b:5,4-c']dipyridine derivatives and their anti-inflammatory effect.
The syntheses and anti-inflammatory activities of novel thieno[2,3-b]pyridine and thieno[2,3-b:5,4-c']-dipyridine derivatives are… 
1998
1998
Double column-switching high-performance liquid chromatographic method for the determination of TAK-603 and its metabolites in human serum.
1997
1997
Reduction of disease causative T-cells in experimental autoimmune disease models by a new antirheumatic drug, TAK-603.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)